ReviewJournal of clinical medicine2026
Treatment of Large-Diameter Truncal Veins: A Structured Review of Contemporary Endovenous and Surgical Modalities.
Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Truncal vein insufficiency can be treated with endovenous thermal ablation (EVTA), non-thermal non-tumescent techniques, ultrasound-guided foam or microfoam sclerotherapy, and high ligation with stripping. However, the optimal management of large-diameter truncal veins remains unclear. This structured review summarizes treatment outcomes in large-diameter incompetent truncal veins and compares available modalities according to vein diameter, anatomical success, recurrence, reintervention, and complications. A PubMed/MEDLINE search was performed for studies published between January 2000 and June 2026. Studies were eligible if they specifically evaluated incompetent great saphenous veins, small saphenous veins, or accessory saphenous veins described as large-diameter, large-caliber, very large, enlarged, or wide-diameter truncal veins. Twenty-three primary studies met the inclusion criteria. Definitions of large-diameter veins varied widely, ranging from >8 mm to >20 mm. EVTA represented the largest evidence base and generally showed high anatomical success, with most studies reporting occlusion, recurrence-free, or recanalization-free rates above 90%. Foam-based treatment, cyanoacrylate closure, and mechanochemical ablation were supported by fewer large-vein-specific studies, and durability in larger veins remains less certain. High ligation and stripping showed low recurrence or residual stump rates in selected comparative studies, but outcome definitions differed from endovenous occlusion endpoints. Current evidence supports individualized treatment selection based on vein diameter, anatomy, tortuosity, reflux pattern, and expected durability. Dedicated randomized trials using standardized diameter definitions and outcome reporting are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.